LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | +50.0% | 32 | +23.1% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 26 | +225.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -97.1% | 8 | -96.9% | 0.00% | -100.0% |
| Q3 2021 | $35,000 | +29.6% | 256 | +21.9% | 0.00% | +100.0% |
| Q2 2021 | $27,000 | +50.0% | 210 | +78.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +125.0% | 118 | +43.9% | 0.00% | -50.0% |
| Q4 2020 | $8,000 | -97.6% | 82 | -97.7% | 0.00% | -90.9% |
| Q3 2020 | $338,000 | -7.9% | 3,548 | +8.1% | 0.02% | -8.3% |
| Q2 2020 | $367,000 | -18.4% | 3,281 | -47.0% | 0.02% | -31.4% |
| Q1 2020 | $450,000 | +782.4% | 6,196 | +3231.2% | 0.04% | +775.0% |
| Q3 2018 | $51,000 | -99.8% | 186 | +66.1% | 0.00% | +100.0% |
| Q2 2018 | $23,204,000 | +580000.0% | 112 | +250.0% | 0.00% | – |
| Q4 2017 | $4,000 | 0.0% | 32 | +14.3% | 0.00% | – |
| Q3 2017 | $4,000 | -97.8% | 28 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $179,000 | – | 1,499 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |